Héla Karray
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 4
-
- Head and Neck Cancer Studies 7
- Co-authors
- Mounir Frikha (6 shared papers)Jamel Daoud (6 shared papers)Adnane Hammami (9 shared papers)Abdelmajid Khabir (8 shared papers)Tahia Sallami Boudawara (5 shared papers)Lamia Fki‐Berrajah (14 shared papers)RACHID JLIDI (3 shared papers)M. Frikha (5 shared papers)
In The Last Decade
Héla Karray
44 papers receiving 808 citations
Peers
Comparison fields: 5 of 68
- Otorhinolaryngology 162
- Infectious Diseases 261
- Oncology 151
- Modeling and Simulation 22
- Epidemiology 98
Countries citing papers authored by Héla Karray
This map shows the geographic impact of Héla Karray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Héla Karray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Héla Karray more than expected).
Fields of papers citing papers by Héla Karray
This network shows the impact of papers produced by Héla Karray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Héla Karray. The network helps show where Héla Karray may publish in the future.
Co-authors
The 25 scholars most cited alongside Héla Karray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 157 | |
| 2 | 2022 | 114 | |
| 3 | 2005 | 61 | |
| 4 | 2005 | 56 | |
| 5 | Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients. | 2008 | 39 |
| 6 | 2001 | 34 | |
| 7 | 2007 | 30 | |
| 8 | [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)]. | 2001 | 29 |
| 9 | 2007 | 21 | |
| 10 | 2018 | 21 | |
| 11 | 2009 | 20 | |
| 12 | 2012 | 19 | |
| 13 | 2006 | 18 | |
| 14 | 2009 | 16 | |
| 15 | 2014 | 14 | |
| 16 | 2022 | 14 | |
| 17 | 2010 | 13 | |
| 18 | 2012 | 13 | |
| 19 | 2020 | 13 | |
| 20 | 2009 | 12 |
About Héla Karray
Héla Karray is a scholar working on Infectious Diseases, Otorhinolaryngology, Epidemiology, Oncology and Hepatology, having authored 54 papers that have together received 846 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (8 papers), Head and Neck Cancer Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Virology and Viral Diseases (5 papers), Hepatitis B Virus Studies (4 papers), Mosquito-borne diseases and control (4 papers), SARS-CoV-2 detection and testing (4 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Otorhinolaryngology (162 citations), Infectious Diseases (261 citations), Oncology (151 citations), Modeling and Simulation (22 citations) and Epidemiology (98 citations). Héla Karray has collaborated with scholars based in Tunisia, France and Nigeria. Frequent co-authors include Mounir Frikha, Jamel Daoud, Adnane Hammami, Abdelmajid Khabir, Tahia Sallami Boudawara, Lamia Fki‐Berrajah, RACHID JLIDI, M. Frikha, Jaap Michiel Middeldorp and J. Daoud. Their work appears in journals such as Virology, Science, Microbial Genomics, Journal of Medical Virology and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.